SCHEMBL22166100

SCHEMBL22166100

O=c1c2ccccc2nc(CSc2ncnc3[nH]ccc23)n1-c1ccccc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.67
HSD17B10 Q99714 2/20 0.67
RXFP1 Q9HBX9 1/20 0.67
KDM4E B2RXH2 2/20 0.56
HPGD P15428 2/20 0.56
THRB P10828 1/20 0.56
CDC7 O00311 2/20 0.56
DBF4 Q9UBU7 2/20 0.56
GAA P10253 1/20 0.54
SMN1; SMN2 Q16637 3/20 0.54
PIK3CG P48736 2/20 0.52
POLB P06746 1/20 0.52
RECQL P46063 1/20 0.52
MAPT P10636 3/20 0.52
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
HTT P42858 1/20 0.52
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
NOTUM Q6P988 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL734395 0.84 ALDH1A1 (0.72) ALDH1A1HSD17B10RXFP1KDM4EHPGD
SCHEMBL735258 0.79 ALDH1A1 (0.67) ALDH1A1HSD17B10RXFP1KDM4EHPGD
SCHEMBL735179 0.79 HSD17B10 (0.64) ALDH1A1HSD17B10RXFP1KDM4EHPGD
SCHEMBL733471 0.77 HSD17B10 (0.61) ALDH1A1HSD17B10RXFP1KDM4EHPGD
SCHEMBL20409291 0.77 ALDH1A1 (0.61) ALDH1A1HSD17B10RXFP1KDM4EHPGD
SCHEMBL734722 0.75 ALDH1A1 (0.59) ALDH1A1HSD17B10RXFP1KDM4EGAA
SCHEMBL24846338 0.75 ALDH1A1 (0.75) ALDH1A1HSD17B10RXFP1KDM4EHPGD
SCHEMBL18415242 0.74 SMN1; SMN2 (0.77) ALDH1A1HSD17B10RXFP1KDM4EHPGD
SCHEMBL12264959 0.74 ALDH1A1 (0.57) ALDH1A1HSD17B10RXFP1KDM4EHPGD
SCHEMBL735038 0.73 PIK3CG (0.75) ALDH1A1HSD17B10RXFP1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10695349-B2 Inhibitors of human phosphatidylinositol 3-kinase delta ICOS CORPORATION (US) 2020-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10695349-B2 Inhibitors of human phosphatidylinositol 3-kinase delta PIK3CD, PIK3CA, PIK3CG ALDH1A1 4628/4885HSD17B10 2243/4885RXFP1 4856/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.